Login
$JOCM
$1.18 +$0.00 (0.0%) Close

Consolidated Balance Sheets

In USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
ASSETS
NON-CURRENT ASSETS
Intangible asset
Plant and equipment, net
Operating lease right of use asset
Total Non-Current Assets
CURRENT ASSETS
Cash and bank balances
Deposits
Deposits and prepayment
Other receivable
Total Current Assets
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Other payables
Related Party
Total other payables
Amount due to directors
Related Party
Director
Total amount due to directors
Income tax payable
Leased Liabilities
TOTAL CURRENT LIABILITIES
TOTAL LIABILITIES
STOCKHOLDERS’ EQUITY
Common Shares, par value $0.0001; 600,000,000 shares authorized, 65,680,500 shares issued and outstanding as of December 31, 2025 as compared to 57,680,500 shares issued and outstanding as of December 31, 2024.
Additional paid-in capital
Subscription receivable
Exchange translation reserve
Accumulated losses
TOTAL STOCKHOLDERS’ EQUITY
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support